Feb 07, 2019

Fagron Launches New Brand Identity and Purpose

Fagron today launched its new brand identity, with its redefined purpose ‘Together we create the future of personalized medicine’. The new brand identity reflects Fagron, our culture, our values, our business segments, while also reflecting our devotion and passion to improve personalized medicine.

Rafael Padilla, CEO of Fagron: “Our purpose reflects our commitment to improve personalized medicine through meaningful innovation. Together, with prescribers, pharmacists and customers, using the innovative power of our growing company and embracing the opportunities personalized medicine has to offer. As a leading player, we aim to lead and take responsibility to further shape and grow the world of personalized medicine. This improves the quality of life and will drive our future growth” 

New logo - Connecting the dots
The new brand identity consists of a powerful logo, a new brand architecture and a brand line. Together, it creates one, distinctive global brand and supports Fagron’s strategic vision to create the future of personalized medicine.

The logo consists of nine dots. Every dot represents an important element of Fagron’s identity. Acknowledging heritage, valuing today and embracing the future. Fagron puts its customer first; the customer is represented by the first red dot. Surrounded by red dots that represent business values deemed to be crucial to deliver on our purpose; speed of execution, entrepreneurship, creativity and quality. Quality is at the center of our new logo, emphasizing that quality is in the middle of our daily operations and main center of reference. The sixth and last red dot stands for the core business being pharmaceutical compounding.

The subsequent three grey dots symbolize the evolution of new business segments that have recently been introduced:
  • Fagron Genomics: Development, production and marketing of innovative genetic tests. The genetic analysis, with algorithm-based software developed by Fagron, takes place in the state-of-the-art Next Generation Sequencing laboratory of Fagron Genomics in Barcelona (Spain).
  • FagronLab: R&D and analytic services for personalized medicine.
  • Fagron Tech: Software and digital technological solutions for personalized medicine.

About Fagron, Inc.
Fagron, Inc., a Fagron global company, is a leading developer and supplier of innovative delivery vehicles (creams, syrups, and lotions), bulk pharmaceutical ingredients, excipients, and high quality compounding equipment. Based in St. Paul, MN, it is a US FDA and DEA-registered pharmaceutical manufacturer that strictly adheres to current Good Manufacturing Practices (cGMP). All batches are tested for identity, strength, quality, purity and compliance with relevant USP or other monographs in Fagron's in-house analytical laboratory. For more information, visit fagron.us.

Market Buzz

Feb 18, 2019 QS/1® Offers Compliance Packaging Label Solution
Feb 15, 2019 QS/1 Partnership Offers Compliant Patient Communications
Feb 14, 2019 RXinsider is Proud to Welcome our Newest Partners!
Feb 12, 2019 Albertsons Companies Pharmacies Adopt TemperPack's ClimaCell™ Packaging
Feb 07, 2019 Fagron Launches New Brand Identity and Purpose
Feb 07, 2019 Medicine-On-Time has come together with Clinical Support Services, a leader in M...
Feb 04, 2019 Letco Med and Ananda Professional Partner to Bring CBD and Education to Compound...
Jan 30, 2019 Texas Children’s Hospital Expands Partnership with Omnicell
Jan 16, 2019 Helmer Scientific Launches the First Professional Medical-grade Refrigerators
Jan 15, 2019 The Compliance Team™ celebrates 25 years of accreditation transformation
Jan 11, 2019 CORE Higher Education Group partners with Pharmacists Mutual
Jan 10, 2019 SCA Pharma Awarded National Outsourced I.V. Admixture Services Agreement with Pr...
Jan 08, 2019 Tutela Welcomes the Center for Organ Recovery and Education
Dec 13, 2018 PharmaLink Launches Updated Website
Dec 11, 2018 Jorgenson Issues Annual List of Major Challenges Facing Hospital and Health Syst...
Nov 29, 2018 BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversi...
Nov 13, 2018 Akro-Mils 2019 Catalog
Nov 13, 2018 New Data Shows Many Health System Pharmacies Considering Consolidated Distributi...
Oct 17, 2018 Retail Management Solutions Celebrates 20 Years of Pharmacy POS Innovation
Oct 17, 2018 Hardy Diagnostics Releases a New Locking Lid Feature for all Contact Plates
Oct 15, 2018 Transaction Data Systems Partners with Community Pharmacies to Fight the Opioid ...
Oct 12, 2018 1st Patient-Centered Respiratory Home™ Accreditation Recipient Named
Oct 10, 2018 Augusta University Health Selects Omnicell’s Industry-Leading Medication Manag...
Oct 04, 2018 QS/1® Honors Pharmacists at NCPA
Oct 03, 2018 Innovation to Move to New Campus in New York’s Southern Tier to Accommodate St...
Oct 03, 2018 Equashield and Max Care Medical to Distribute Leading Closed System Transfer Dev...
Oct 01, 2018 Global Needlefree Closed System Transfer Device (CSTD) Market 2018 by Manufactur...
Sep 23, 2018 Prudential Overall Supply Celebrates Dan Clark's 50th Employment Anniversary
Sep 19, 2018 RXQ Compounding Expanding in Albany
Sep 17, 2018 Middlesex Hospital Bolsters Pharmacy Safety and Compliance by Extending Wolters ...

RXinsider Product Overview Videos